Spirax-Sarco takes over closed Brazilian firm Hiter

Josh White WebFG News | 09 Aug, 2016 07:54 - Updated: 08:54 | | |

spirax sarco, spirax-sarco, engineering, pump, industry, industrial, manufacturing
  • 5,715.00
  • -0.26%-15.00
  • Max: 5,730.00
  • Min: 5,685.00
  • Volume: 8,161
  • MM 200 : n/a
09:25 20/11/17
  • 19,843.94
  • 0.23%46.11
  • Max: 19,844.28
  • Min: 19,738.62
  • Volume: 0
  • MM 200 : n/a
09:30 20/11/17
  • 12,089.33
  • 0.03%3.08
  • Max: 12,101.58
  • Min: 12,024.26
  • Volume: 0
  • MM 200 : n/a
09:25 20/11/17
  • 4,094.71
  • -0.19%-7.96
  • Max: 4,102.67
  • Min: 4,087.46
  • Volume: 0
  • MM 200 : n/a
09:30 20/11/17
  • 4,044.21
  • -0.19%-7.57
  • Max: 4,051.79
  • Min: 4,037.33
  • Volume: 0
  • MM 200 : n/a
09:30 20/11/17

Steam and peristaltic pumping engineering company Spirax-Sarco Engineering announced on Tuesday that on 1 July it acquired the assets of the process control valve manufacturer, Hiter Indústria e Comércio de Controles Termo-Hidráulicos, based in Sorocaba, Brazil.

The FTSE 250 firm said Hiter was a subsidiary of Pentair, which is listed on the New York Stock Exchange.

Spirax said Hiter is “highly synergistic” with Spirax-Sarco's successful Brazilian steam and process fluid applications business.

“The Hiter brand has a well established reputation in Brazil with a large installed base and had net sales of over £7m in 2015,” Spirax’s board said in a statement.

Following the acquisition, Spirax becomes the only significant manufacturer of both control and safety valves in Brazil.

Hiter has undergone significant change in recent years as part of Pentair's Valves & Controls segment, resulting in a December 2015 announcement to close the company effective March 2016.

The assets have been acquired by a new Spirax subsidiary, Hiter Controls Engenharia Ltda, which will commence trading in the fourth quarter of 2016.

“It is anticipated that the start-up and pre-operating losses incurred in 2016 will reach £1.2m on negligible sales.

“ After re-establishing Hiter's market position during 2017, this business is forecast to make a positive contribution to Group earnings from 2018,” the board explained.

The total purchase consideration of £3.9m was paid in cash from existing group resources, Spirax confirmed.

More news

08:44 London open: Stocks in the red as attention turns to Germany

London stocks fell in early trade on Monday, with sentiment undermined by developments in Germany.

08:35 Wood Group inks operating partnership with Ancala for North Sea pipeline

Energy services firm John Wood Group began operations on a multi-million dollar contract on Monday that would see it act as the operating partner of the Scottish Area Gas Evacuation (SAGE) system and Beryl pipeline.

08:24 Mediclinic withdraws as Spire Healthcare rejects renewed offer

Mediclinic International has walked away from talks to take over Spire Healthcare after the UK-focused hospital operator rejected a renewed offer.

08:03 Nex profit drops amid challenging market conditions, more cost savings identified

Financial technology company Nex Group posted a drop in first-half profit on Monday amid challenging market conditions.

07:51 Mitie first-half profit drops despite revenue rise

FTSE 250 outsourcer Mitie posted a drop in profit for the first half on Monday despite a rise in revenue, as it continues to invest in its cost-saving programme.

07:38 London pre-open: Stocks seen slightly lower; Budget in focus

London stocks were set for a slightly weaker open on Monday following an uninspiring session in Asia, as investors looked ahead to the Budget this week.

07:37 Centrica replacing variable tarriff with fixed-term options, Wizz Air announces massive Luton expansion

London open

19 Nov US close: Stocks end week on a soft note, White House in focus

Wall Street went into the weekend before Thanksgiving Day slightly lower, with analysts continuing to mull developments regarding Russia's alleged involvement in the US presidential election.

19 Nov Week ahead: Spotlight on Hammond

In the UK, the focus will be on the Chancellor's Budget on Wednesday, with fresh data on public sector net borrowing on Tuesday possibly helping to set the tone for his announcements.

19 Nov Sunday share tips: Merlin Entertainments, Amryt Pharma

Stock in Merlin Entertainments is best avoided, The Sunday Times's John Collingridge says, pointing to the increasing headwinds the company is facing in the UK which will be compounded by the outfit's strategy of focusing on growth overseas.